Loading page…
A software-led hearing-care venture paired lower-priced devices with retail distribution as US over-the-counter rules changed.
$3M+ in one day on a later promotion · device priced at $799
Regulatory change created the opening; retail readiness, inventory and contract economics determined whether the demand could become profitable scale.
Fewer bars = easier, cheaper, or faster for an AI-assisted solo builder. Editorial judgments based on the case details.
Nic Klopper describes hearX as a South African university spinout that spent almost two years pre-revenue while developing a medically regulated hearing product. Rather than manufacture a hearing aid from scratch, the company built a software platform and partnered with a US supplier to co-develop a device. The product sold for $799, compared with the $5,000 hearing aids cited in the conversation, and was available over the counter without the traditional audiologist prescription process. hearX piloted in 500 US stores before the regulatory change. When US OTC rules changed in October 2022, Klopper says the company entered 13,500 stores. The sudden demand caused stockouts within seven days. He reports more than $2 million a month in OTC sales in one year and later describes a promotional day exceeding $3 million. These are founder-reported sales figures, not audited revenue or profit. The story is a scale reference for regulated consumer health hardware paired with software and retail execution.
For a regulated hearing product, the first customers need confidence in safety, fit and support before they will buy.
The quick-reference card — acquisition channels, replication playbook, risks & traps, and our verdict — is members-only.
Join the Unicorn Club — $5/moCancel anytime, in one clickPaste into Claude Code / Codex and get a working version of this product end-to-end.
Two production-grade prompts per idea — a full build spec and an SEO growth plan — plus 10 tailored build specs a week. Members only.
Join the Unicorn Club — $5/moCancel anytime, in one clickEvery claim traces back to a listed source — open any of them and check the number yourself. The exact words are quoted below, with a timestamp that jumps to the second each figure is said.
“Um, but then we had this business doing, you know, 20x that, you know, we were doing more than $2 million a month in OTC sales and we're doing that in a year.”
37:51 · hear it in the videoData credibility: Nic Klopper, hearX co-founder and former CEO, reports the product price, store footprint, sales figures, fundraising and costs during an interview. Figures are founder-reported and unaudited; the transcript does not provide independent financial statements. Store access and sales should not be read as profit.
The first dollar for a hearing device business arrives when a qualified customer completes a purchase through a credible channel and the sale leaves enough contribution margin to cover fulfillment and service. hearX’s early commercial path included a limited retail pilot, with its $799 device…
A retail health product flywheel depends on evidence that the product sells, retailers can replenish it, and customers receive reliable support. hearX’s pilot gave it a foothold before the US regulatory change; its presence in 13,500 stores on the change date then made the product widely available…
A regulated hardware company can spend years building approvals and supplier relationships before customers can buy. Klopper says hearX was pre-revenue for almost two years because the product was medically regulated.
hearX combined a software platform with a partner-manufactured hearing device. The founders did not start by building every component themselves; they sought a supplier with a suitable device and co-developed a product that could be sold over the counter. The software layer and consumer experience helped distinguish the offer from the traditional model that Klopper describes as requiring a $5,000 hearing aid and an audiologist prescription. This architecture can reduce manufacturing burden, but it makes supplier selection, quality control, regulatory scope and long-term availability central product decisions. A founder should map the complete journey from customer discovery through fit, use, troubleshooting and professional referral. In hearing care, onboarding and human support are product features because a device that is technically functional can still fail if the customer cannot use it confidently. The retail version needs simple demonstrations, clear labeling and a dependable returns path. The software should support the customer and operating team rather than obscure the device’s limitations.
The commercial model combines device sales with retail distribution. The founder cites a $799 selling price and says OTC sales later exceeded $2 million a month in one year. On a separate promotional day, the business exceeded a $3 million target. Those figures describe sales activity and do not establish gross margin or net profit. Retail distribution can expand reach quickly, but retailer terms may include marketing contributions, payment timing, exclusivity and other obligations. Klopper recounts a $4 million marketing co-op charge that nearly consumed the profit from that year’s retail business. Before entering a chain, model contribution margin under each contract clause and run scenarios for returns, discounts, co-op spend, late payment and inventory carrying costs. Negotiate definitions and caps rather than assuming a standard percentage is harmless. Direct sales may preserve more margin and customer data, while retail offers reach and credibility. A balanced channel strategy should compare customer acquisition cost, sell-through, service burden and working capital by channel. Revenue scale only matters when each channel can contribute cash after its full cost.
This is a capital-intensive model even though the software layer may be comparatively light. Product development, regulatory work, inventory, retail onboarding, logistics, customer support and working capital all require meaningful funding. Klopper says the business raised $36 million in the year it scaled and describes an $8 million Walgreens deployment that covered 8,000 of the 13,000 stores in that rollout. He also discusses a $4 million marketing co-op cost. The transcript’s sales and fundraising figures are founder-reported and should not be mistaken for profit. A founder should build a per-unit model that includes device cost, packaging, freight, retailer margin, promotional contributions, returns, warranty replacements and support. Use conservative demand scenarios and a cash conversion cycle forecast before committing to store volume. Hire or contract specialist regulatory and retail expertise early enough to review obligations before signature. Monitor stockouts, working capital, support wait times and margin by channel weekly during launches. Demand can grow faster than the operating system, and that gap can turn a promising rollout into expensive lost sales and customer frustration.
Copy the choice to solve a costly customer problem with a lower-friction product and to prepare distribution before a regulatory opening. hearX worked with a device partner rather than attempting to develop every hardware component internally, and it proved the offer in a limited store pilot before scaling. A new founder should also treat compliance and commercial terms as product design constraints from day one. Change the assumption that a large retail footprint automatically equals a successful business. Validate sell-through, gross margin, return rates, stock reliability and support capacity in a controlled market first. Build a contract review process before engaging major chains, including an independent review of marketing funds, exclusivity, payment and logistics clauses. Keep one team accountable for local customer insight; Klopper says moving sales support away from the US market was the wrong choice because the remote team lacked local nuance. The case is most relevant to founders who can fund long regulatory cycles and coordinate hardware, software and retail. It is not a template for a low-cost solo SaaS launch.
Regulatory, product quality and commercial execution risks all compound in over-the-counter health hardware. A product can be compliant and still fail customers if labeling, fit guidance or support is inadequate. Supplier dependence can limit availability or create quality problems, while aggressive retail expansion can consume cash before sell-through is proven. The hearX story includes stockouts within seven days of a demand surge, an hour-and-a-half support wait, and a $4 million marketing co-op obligation that nearly erased profit from that business for the year. These are concrete warnings about capacity and contract economics. Build inventory buffers based on realistic launch scenarios, define escalation procedures for support, and review store-level sell-through before committing to more locations. Keep sales and support close to local customer context. Protect cash with a working-capital plan that covers retailer payment delays and returns. Finally, avoid broad health claims and maintain specialist oversight as rules evolve. A rollout can create impressive top-line volume while leaving the company with thin margins and a fragile customer experience.
The four founder playbooks — first customers, first dollar, the flywheel, the silent stretch — are in the Unicorn Club, on this idea and on all 1,403 others. The story, the numbers, the sources and every later section stay open to everyone.
Join the Unicorn Club — $5/moCancel anytime, in one click